CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
-3.59%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$258M
AUM Growth
+$258M
(-6.8%)
Cap. Flow
+$12.3M
Cap. Flow
% of AUM
4.77%
Top 10 Holdings %
Top 10 Hldgs %
29.62%
Holding
474
New
111
Increased
42
Reduced
30
Closed
113
Top Buys
| 1 |
Caesars Entertainment
CZR
|
$23.7M |
| 2 |
Exact Sciences
EXAS
|
$9.03M |
| 3 |
Five Below
FIVE
|
$6.65M |
| 4 |
Cigna
CI
|
$5.24M |
| 5 |
RTX Corp
RTX
|
$4.79M |
Top Sells
| 1 |
DaVita
DVA
|
$11.3M |
| 2 |
News Corp Class A
NWSA
|
$6.6M |
| 3 |
Charter Communications
CHTR
|
$6.52M |
| 4 |
LiveRamp
RAMP
|
$5.45M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$5.42M |
Sector Composition
| 1 | Consumer Discretionary | 28.35% |
| 2 | Healthcare | 21.62% |
| 3 | Technology | 12.61% |
| 4 | Communication Services | 7.16% |
| 5 | Energy | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
101
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $593K | 0.05% |
24,800
+18,800
| +313% | +$450K |
|
|
PVG
102
DELISTED
PRETIUM RESOURCES INC.
PVG
| $591K | 0.05% |
+70,000
| New | +$591K |
|
|
SFLY
103
DELISTED
Shutterfly, Inc.
SFLY
| $587K | 0.05% |
14,600
-4,500
| -24% | -$181K |
|
104
McDonald's
MCD
$226B
| $568K | 0.05% |
+3,200
| New | +$568K |
|
105
GE Aerospace
GE
$293B
| $568K | 0.05% |
+75,000
| New | +$568K |
|
106
Merit Medical Systems
MMSI
$5.34B
| $558K | 0.04% |
+10,000
| New | +$558K |
|
107
Carlyle Group
CG
$22.9B
| $551K | 0.04% |
35,000
+2,600
| +8% | +$40.9K |
|
|
TRQ
108
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $541K | 0.04% |
328,000
+78,000
| +31% | +$129K |
|
109
D.R. Horton
DHI
$51.3B
| $520K | 0.04% |
15,000
-59,500
| -80% | -$2.06M |
|
110
AXIS Capital
AXS
$7.68B
| $516K | 0.04% |
+10,000
| New | +$516K |
|
111
PTC Therapeutics
PTCT
$4.41B
| $514K | 0.04% |
+15,000
| New | +$514K |
|
112
Generac Holdings
GNRC
$10.3B
| $497K | 0.04% |
+10,000
| New | +$497K |
|
113
Freeport-McMoran
FCX
$66.3B
| $495K | 0.04% |
48,000
-24,000
| -33% | -$248K |
|
114
Bristol-Myers Squibb
BMY
$96.7B
| $494K | 0.04% |
+9,500
| New | +$494K |
|
115
BGC Group
BGC
$4.64B
| $491K | 0.04% |
95,000
-45,000
| -32% | -$634K |
|
|
CS
116
DELISTED
Credit Suisse Group
CS
| $488K | 0.04% |
45,000
-45,000
| -50% | -$488K |
|
|
MRNS
117
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $487K | 0.04% |
170,000
-18,500
| -10% | -$53K |
|
118
Conduent
CNDT
$444M
| $479K | 0.04% |
+45,000
| New | +$479K |
|
119
LKQ Corp
LKQ
$8.23B
| $474K | 0.04% |
+20,000
| New | +$474K |
|
|
ADMS
120
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $470K | 0.04% |
55,000
+18,552
| +51% | +$159K |
|
121
Nutrien
NTR
$27.6B
| $470K | 0.04% |
+10,000
| New | +$470K |
|
122
Brunswick
BC
$4.15B
| $465K | 0.04% |
+10,000
| New | +$465K |
|
123
Vistra
VST
$63.7B
| $459K | 0.04% |
20,000
-100,000
| -83% | -$2.3M |
|
|
CLDR
124
DELISTED
Cloudera, Inc.
CLDR
| $443K | 0.04% |
40,000
| – | – |
|
125
Ambac
AMBC
$423M
| $431K | 0.03% |
25,000
| – | – |
|